Clinical Research Directory
Browse clinical research sites, groups, and studies.
Long-term Observational Study of Patients Treated With Inaticabtagene Autoleucel Injection
Sponsor: Juventas Cell Therapy Ltd.
Summary
This clinical trial adopts an observational research method to conduct annual follow-up and monitoring of patients receiving treatment with Inaticabtagene Autoleucel Injection after its commercialization, in order to evaluate the delayed adverse events of Inaticabtagene Autoleucel Injection.
Official title: A Long Term Follow-up Observational Study of Patients Treated With Inaticabtagene Autoleucel Injection
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2024-03-30
Completion Date
2040-03-30
Last Updated
2025-08-07
Healthy Volunteers
No
Conditions
Interventions
Inaticabtagene autoleucel Injection
Inaticabtagene autoleucel Injection
Locations (1)
Institute of Hematology & Blood Diseases Hospital
Tianjin, Tianjin Municipality, China